Tech Company Financing Transactions
Vaderis Therapeutics Funding Round
On 8/11/2026, Vaderis Therapeutics raised $152 million in Series B funding from Goldman Sachs, TCGX and Droia Ventures.
Transaction Overview
Company Name
Announced On
8/11/2026
Transaction Type
Venture Equity
Amount
$152,000,000
Round
Series B
Investors
Goldman Sachs (Lead Investor)
TCGX (Lead Investor)
Proceeds Purpose
The company intends to use the funds to fund planned operations through regulatory submissions and potential U.S. regulatory approval for engasertib (VAD044), as well as to support its global Phase 3 HEROIC clinical study evaluating engasertib in patients with hereditary hemorrhagic telangiectasia (HHT).
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Lichtstrasse 35, Building WSJ-350
Basel, CH-4056
Switzerland
Basel, CH-4056
Switzerland
Phone
Undisclosed
Website
Email Address
Overview
Vaderis is a science-driven, patient-focused biotech with a singular aim: to be the first to bring breakthrough therapies to people with HHT and other rare vascular diseases. Our work is guided by deep biological insight, a relentless commitment to rigorous science, impeccable execution and an unwavering belief that meaningful change is possible. We advance with purpose, inspired by the patients who drive us forward and by the promise of what has yet to be achieved. Pioneering care for people with unmet needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Azmi Nabulsi
Chief Medical Officer
Damien Picard
Chief Medical Officer
Darryl Sleep
Chief Operating Officer
Tom Harris
Chief Operating Officer
Karen Zylberman
Chief Scientific Officer
Pierre Saint-Mezard
VP - Human Resources
Moon Kim
VP - Operations
Maria Buckley
Browse more venture capital transactions:
Prev: 8/11/2026: Legio venture capital transaction
Next: 8/11/2026: MarginEdge venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs